PHARMA TESTING

Particle Size Analysis Using Malvern 3000

Laser diffraction particle size analysis for pharmaceutical raw materials, APIs, excipients and formulated dispersions, supporting formulation development, batch consistency and specification-setting.

Laboratory scientist operating a laser diffraction particle-size analyser

Why Particle Size Matters

Particle size can influence key pharmaceutical product characteristics including dissolution rate, bioavailability, content uniformity, stability and manufacturability. Where particle size affects product performance, ICH Q6A recognises particle size distribution as a specification test for drug substances and drug products. For inhalation and nasal products, current EMA guidance places specific emphasis on how particle size is controlled during manufacture.

DALPL provides laser diffraction particle size distribution analysis using a Malvern 3000 particle size analyser, aligned with USP <429> and ISO 13320:2020.

Particle Size
Dissolution Rate
Bioavailability
Content Uniformity
Stability
Manufacturability

What We Test

DALPL's particle size analysis capability covers:

Raw Materials & APIs

Particle size characterization of pharmaceutical raw materials and active pharmaceutical ingredients.

Excipients

Particle size characterization of excipients used in pharmaceutical formulations.

Suspensions & Dispersions

Particle size distribution analysis for oral, nasal, ophthalmic and topical formulations.

Formulation Development

Particle size data supporting formulation development and evaluation.

Batch Consistency

Particle size monitoring to support consistency across batches.

Specification Support

Particle size data supporting specification-setting where particle size affects product performance, in line with ICH Q6A.

Laser Diffraction Analysis

DALPL performs particle size distribution analysis using laser diffraction on a Malvern 3000 particle size analyser.

The analysis is performed with reference to:

USP <429> Light Diffraction Measurement of Particle Size
ISO 13320:2020 Particle Size Analysis — Laser Diffraction Methods

The resulting particle size distribution is reported using key parameters including D10, D50, D90 and span.

Laser Diffraction Analysis

Key Particle Size Parameters

Particle size analysis provides a defined distribution profile rather than relying on a single particle-size value.

D10
Particle size distribution parameter reported through laser diffraction analysis.
D50
Particle size distribution parameter reported through laser diffraction analysis.
D90
Particle size distribution parameter reported through laser diffraction analysis.
Span
Distribution-width parameter reported alongside D10, D50 and D90.

Applications & Development Support

Particle size analysis can support pharmaceutical development and product-control requirements across multiple applications.

Raw Material & API Characterization

Characterize particle size of pharmaceutical raw materials and active pharmaceutical ingredients.

Excipient Characterization

Evaluate particle size characteristics of pharmaceutical excipients.

Formulation Development

Generate particle size data for oral, nasal, ophthalmic and topical suspensions and dispersions.

Batch-to-Batch Consistency

Monitor particle size distribution as part of batch consistency evaluation.

Specification Setting

Support particle size specifications where particle size has an impact on product performance, consistent with ICH Q6A.

Inhaled & Nasal Product Development

Support particle size-related formulation development for inhaled and nasal products within the quality expectations established by current EMA guidance.

Regulatory & Compendial Framework

DALPL's particle size analysis is positioned against the following technical and regulatory references:

ICH Q6A
Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products
Relevant where particle size affects product performance and is established as a specification test.
USP <429>
Light Diffraction Measurement of Particle Size
The compendial chapter governing light-diffraction particle size measurement.
ISO 13320:2020
Particle Size Analysis — Laser Diffraction Methods
The applicable international standard for laser diffraction particle size analysis.
EMA
Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products
Effective from 1 February 2026, with specific expectations around particle size control for inhalation and nasal products.
US FDA
FDA quality considerations for particle size as a critical quality attribute in inhaled drug products.
Regulatory status note: The FDA MDI/DPI quality-considerations document referenced in the technical review is a draft document and is not presented as a binding implementation requirement.

Particle Size vs APSD

A Defined Analytical Scope: This service focuses on laser-diffraction particle size characterization of raw materials, excipients and formulated dispersions. It is distinct from aerodynamic particle size distribution (APSD) testing of inhaler or nasal-spray aerosol plumes, which uses cascade impaction as a separate analytical methodology.

Laser Diffraction

Intended analytical context:

  • Raw materials
  • APIs
  • Excipients
  • Suspensions
  • Dispersions
Aerodynamic Particle Size Distribution

A separate analytical methodology:

  • Inhaler / nasal aerosol plume
  • Cascade impaction
Note: APSD uses cascade impaction as a completely separate analytical methodology from laser diffraction.

Why DALPL

Malvern 3000 Laser Diffraction

Particle size distribution analysis using the Malvern 3000 particle size analyser.

USP <429> & ISO 13320:2020

Testing aligned with established compendial and international laser-diffraction particle-size methods.

Pharma Testing Capability

Particle size analysis is delivered through DALPL's dedicated Pharma Testing Division.

Need Particle Size Analysis for Your Pharmaceutical Product?

Discuss your material, formulation or development requirement with the DALPL Pharma Testing Division.

Get a Particle Size Analysis Quote Talk to a Pharma Testing Expert